Volume 5, Issue 4 (Multidisciplinary Cancer Investigation 2021)                   Multidiscip Cancer Investig 2021, 5(4): 1-2 | Back to browse issues page

‎ 10.30699/mci.5.4.460-2
‎ 20.1001.1.24764922.2021.5.4.1.1

XML Print

The Impact of COVID-19 Pandemic on Lymphedema Visits in the lymphedema Clinic at Motamed Cancer InstituteThe Impact of COVID-19 Pandemic on Lymphedema Fol- low-ups in the Lymphedema Clinic at Motamed Cancer Institute
Zahra Sheikhi-Mobarakeh1 , Hossein Yarmohammadi2 , Ali Montazeri 3
1- Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran & Integrative Oncology Research Group, Breast Cancer Research Center, Mota- med Cancer Institute, ACECR, Tehran, Iran
2- Quality of Life Department, Breast Cancer Research Center, Motamed Cancer Institute, ACECR, Tehran, Iran & Medical Students Research Committee, Shahed University, Tehran, Iran
3- Population Health Research Group, Health Metrics Research Center, Iranian Institute for Health Sciences Research, ACECR, Tehran, Iran , montazeri@acecr.ac.ir
Abstract:   (1173 Views)
The COVID-19 pandemic has greatly  changed the routine medical practice in any field and the care delivery to lymphedema patients is not an exception. The lymphedema clinic at Motamed Cancer Institute (MCI), Tehran primarily was established for the management of breast cancer- related lymphedema (BCRL). However, it is now a referral center for different types of lymphedema from all over Iran. This letter aimed to show the impact of the coronavirus disease 2019 (COVID-19) pandemic on the lymphedema practice in the MCI lymphedema clinic.
Keywords: lymphedema, COVID-19, Cellulitis
Full-Text [PDF 213 kb]   (805 Downloads)    
Select article type: Letters to the Editor |
Received: 2021/03/24 | Accepted: 2021/12/28 | ePublished: 2021/12/28
Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.